Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department
Simon Tulloch,
Jacob Nielsen,
Marlene D. Madsen,
Peter Dieckmann,
Pernille Cedergren,
Vicki Gudmandsen,
Kim L. Mikkelsen,
Doris Østergaard Acta Anaesthesiologica Scandinavica
· Wiley
· 2026-11-04
· DOI: 10.1111/aas.70390
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Simon Tulloch, Jacob Nielsen, Marlene D. Madsen, Peter Dieckmann, Pernille Cedergren, Vicki Gudmandsen et al. Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department. // Acta Anaesthesiologica Scandinavica. – 2026. – DOI: 10.1111/aas.70390. – URL: https://onlinelibrary.wiley.com/doi/10.1111/aas.70390?af=R
Simon Tulloch, Jacob Nielsen, Marlene D. Madsen, Peter Dieckmann, Pernille Cedergren, Vicki Gudmandsen, Kim L. Mikkelsen, & Doris Østergaard (2026). Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.70390
Simon Tulloch, et al. “Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department.” Acta Anaesthesiologica Scandinavica, 2026. doi:10.1111/aas.70390.
@article{Tulloch2026,
title = {Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department},
author = {Tulloch, Simon and Nielsen, Jacob and Madsen, Marlene D. and Dieckmann, Peter and Cedergren, Pernille and Gudmandsen, Vicki and Mikkelsen, Kim L. and Østergaard, Doris},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2026},
doi = {10.1111/aas.70390},
url = {https://onlinelibrary.wiley.com/doi/10.1111/aas.70390?af=R}
}
ABSTRACT Background For half the world's population, headaches represent a major health burden that cripples productivity and mental well‐being. While newer CGRP‐targeted drugs have shown promise for migraines, less is known about how...